Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

In vitro expansion of human cardiac progenitor cells: exploring 'omics tools for characterization of cell-based allogeneic products.

Translational research : the journal of laboratory and clinical medicine - 1 May 2016

Gomes-Alves P, Serra M, Brito C, Ricardo C P, Cunha R, Sousa M F, Sanchez B, Bernad A, Carrondo M J T, Rodriguez-Borlado L, Alves P M

Abstract excerpt

Human cardiac stem/progenitor cells (hCPCs) have been shown to be capable to regenerate contractile myocardium. However, because of their relative low abundance in the heart, in vitro expansion of hCPC is mandatory to achieve necessary quantities for allogeneic or autologous cardiac regeneration therapy applications (10(6)-10(9) cells/patient). Up to now, cell number requirements of ongoing phase I/IIa trials...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell Culture Techniques
Share to Electrophoresis, Gel, Two-Dimensional

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mass Spectrometry

Share to Microspheres

Share to Myocardium

Share to Proteome

Share to Proteomics

Share to Transplantation, Homologous

Source

Identifiers

PMID: 26924043
DOI: 10.1016/j.trsl.2016.02.001

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

In vitro expansion of human cardiac progenitor cells: exploring 'omics tools for characterization of cell-based allogeneic products.PMID 26924043Read ↗

Considerations in designing systems for large scale production of human cardiomyocytes from pluripotent stem cellsSemantic proximity Read ↗

Robust Expansion of Human Pluripotent Stem Cells: Integration of Bioprocess Design With Transcriptomic and Metabolomic CharacterizationSemantic proximity Read ↗

Expansion of 3D human induced pluripotent stem cell aggregates in bioreactors: Bioprocess intensification and scaling-up approaches.Semantic proximity Read ↗

Robust Bioprocess Design and Evaluation of Commercial Media for the Serial Expansion of Human Induced Pluripotent Stem Cell Aggregate Cultures in Vertical-Wheel BioreactorsSemantic proximity Read ↗

A Scalable System for Production of Functional Pancreatic Progenitors from Human Embryonic Stem CellsSemantic proximity Read ↗

Mesenchymal and induced pluripotent stem cell–based therapeutics: a comparisonSemantic proximity Read ↗

Impact of Feeding Strategies on the Scalable Expansion of Human Pluripotent Stem Cells in Single-Use Stirred Tank BioreactorsSemantic proximity Read ↗

Efficient and reproducible generation of human iPSC-derived cardiomyocytes using a stirred bioreactorSemantic proximity Read ↗

The quest to make fully functional human pancreatic beta cells from embryonic stem cells: climbing a mountain in the clouds.Semantic proximity Read ↗

Continuous WNT Control Enables Advanced hPSC Cardiac Processing and Prognostic Surface Marker Identification in Chemically Defined Suspension CultureSemantic proximity Read ↗

Systematic microcarrier screening and agitated culture conditions improves human mesenchymal stem cell yield in bioreactorsSemantic proximity Read ↗

Protein-free media for cardiac differentiation of hPSCs in 2000 mL suspension cultureSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.